ETF DAILY NEWS
BioNTech (NASDAQ:BNTX) Upgraded to “Buy” by Deutsche Bank Aktiengesellschaft
BioNTech (NASDAQ:BNTX – Get Free Report) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating in a report released on Wednesday, MarketBeat.com ...
3 days ago
Benzinga via Yahoo
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New ...
5 days ago
EverSource Wealth Advisors LLC Purchases 252 Shares of BioNTech SE (NASDAQ:BNTX)
The institutional investor owned 489 shares of the company’s stock after buying an additional 252 shares during the period. EverSource Wealth Advisors LLC’s holdings in BioNTech were worth $43,000 ...
BioNTech (NASDAQ:BNTX) Hits New 52-Week Low Following Weak Earnings
BioNTech SE (NASDAQ:BNTX – Get Free Report) shares reached a new 52-week low during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $77.02 and ...
View all
Biotechnology company from Germany
biontech.com
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Wikipedia
More on Yahoo Finance